| S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control L Jia, C Bonaventura, J Bonaventura, JS Stamler Nature 380 (6571), 221-226, 1996 | 2051 | 1996 |
| Blood Flow Regulation by S-Nitrosohemoglobin in the Physiological Oxygen Gradient JS Stamler, L Jia, JP Eu, TJ McMahon, IT Demchenko, J Bonaventura, ... Science 276 (5321), 2034-2037, 1997 | 1321 | 1997 |
| T-cell transfer therapy targeting mutant KRAS in cancer E Tran, PF Robbins, YC Lu, TD Prickett, JJ Gartner, L Jia, A Pasetto, ... New England Journal of Medicine 375 (23), 2255-2262, 2016 | 1251 | 2016 |
| The conduct of drug metabolism studies considered good practice (II): in vitro experiments L Jia, X Liu Current drug metabolism 8 (8), 822-829, 2007 | 345 | 2007 |
| Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug L Jia, JE Tomaszewski, C Hanrahan, L Coward, P Noker, G Gorman, ... British journal of pharmacology 144 (1), 80-87, 2005 | 317 | 2005 |
| Current evaluation of the millennium phytomedicine-ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations L Jia, Y Zhao Current medicinal chemistry 16 (19), 2475-2484, 2009 | 314 | 2009 |
| Current evaluation of the millennium phytomedicine-ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese … L Jia, Y Zhao, XJ Liang Current medicinal chemistry 16 (22), 2924-2942, 2009 | 311 | 2009 |
| Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas S Kummar, A Chen, J Ji, Y Zhang, JM Reid, M Ames, L Jia, M Weil, ... Cancer research 71 (17), 5626-5634, 2011 | 297 | 2011 |
| Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis XJ Liang, H Meng, Y Wang, H He, J Meng, J Lu, PC Wang, Y Zhao, X Gao, ... Proceedings of the National Academy of Sciences 107 (16), 7449-7454, 2010 | 293 | 2010 |
| Polynitrosylated Proteins: Characterization, bioactivity and functional consequences. JS Simon, D.I., Mullins, M.E., Jia, L., Gaston, B., Singel, D. J., Stamler Proc. Natl. Acad. Sci. U.S.A. 93, 4736-4741, 1996 | 231* | 1996 |
| Compilation of 222 Drugs’ Plasma Protein Binding Data and Guidance for Study Designs. L Zhang, F., Xie, JP., Shao, JW., Jia Drug Discovery Today 17, 475-495, 2012 | 218 | 2012 |
| A chemical-inducible CRISPR–Cas9 system for rapid control of genome editing KI Liu, MNB Ramli, CWA Woo, Y Wang, T Zhao, X Zhang, GRD Yim, ... Nature chemical biology 12 (11), 980-987, 2016 | 214 | 2016 |
| Nanotechnology-based intelligent drug design for cancer metastasis treatment Y Gao, J Xie, H Chen, S Gu, R Zhao, J Shao, L Jia Biotechnology advances 32 (4), 761-777, 2014 | 206 | 2014 |
| Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer H Nie, X Xie, D Zhang, Y Zhou, B Li, F Li, F Li, Y Cheng, H Mei, H Meng, ... Nanoscale 12 (2), 877-887, 2020 | 171 | 2020 |
| EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery X Xie, F Li, H Zhang, Y Lu, S Lian, H Lin, Y Gao, L Jia European Journal of Pharmaceutical Sciences 83, 28-35, 2016 | 168 | 2016 |
| Biopharmaceutics and therapeutic potential of engineered nanomaterials XJ Liang, C Chen, Y Zhao, L Jia, PC Wang Current drug metabolism 9 (8), 697-709, 2008 | 164 | 2008 |
| Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2–transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048) S Kitada, CL Kress, M Krajewska, L Jia, M Pellecchia, JC Reed Blood, The Journal of the American Society of Hematology 111 (6), 3211-3219, 2008 | 150 | 2008 |
| Nanoparticle formulation increases oral bioavailability of poorly soluble drugs: Approaches, experimental evidences and theory L Jia Current nanoscience 1 (3), 237-243, 2005 | 146 | 2005 |
| Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy Z Jiang, J Shao, T Yang, J Wang, L Jia Journal of pharmaceutical and biomedical analysis 87, 98-104, 2014 | 145 | 2014 |
| Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer F Li, H Mei, Y Gao, X Xie, H Nie, T Li, H Zhang, L Jia Biomaterials 145, 56-71, 2017 | 144 | 2017 |
Jingwei ShaoCancer Metastasis Alert and Prevention Center, College of Chemistry and ChemicalVerified email at fzu.edu.cn
